EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis

Huakang Li, Jianlong Ke, Xiaoyan Wang, Bo Xu, Qiang Li, Ziliang Wu, Yue Wang, Bing Lin iD

Oral Diseases · 2024

DOI: 10.1111/odi.14745 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, 2024. Verfasst von Huakang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Chemoradiotherapy, Stomatitis, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Department Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This clinical trial aimed to evaluate the efficacy and safety of Jiandu granule, a Chinese herbal medicine formula, for preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Materials and Methods A single‐centre, open‐label, randomised controlled trial was conducted, enrolling 138 patients with locally advanced nasopharyngeal carcinoma. Patients were randomly allocated to either the experimental group ( n = 69) or the control group ( n = 69). Both groups received concurrent chemoradiotherapy and standard care for oral mucositis, with the experimental group additionally receiving Jiandu granule intervention. The primary outcome was the incidence of severe oral mucositis (grade III to IV).

Results

In the full‐analysis set, severe oral mucositis occurred in 14 of 69 (20.3%) patients in the experimental group and 31 of 69 (44.9%) patients in the control group (absolute risk reduction: 24.6%; relative risk reduction: 54.8%; p = 0.002; number needed to treat: 4). Jiandu granule was associated with mild/moderate gastrointestinal reactions, with an overall incidence of 5.9%.

Conclusion

Jiandu granule reduced the incidence of severe oral mucositis in nasopharyngeal carcinoma patients during concurrent chemoradiotherapy and had an acceptable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalChemoradiotherapyStomatitisNasopharyngeal NeoplasmsHumansMaleFemaleMiddle AgedAdultNasopharyngeal CarcinomaAged

Stichwörter der Autor:innen

Chinese herbal medicine formulaconcurrent chemoradiotherapynasopharyngeal carcinomaoral mucositisrandomised controlled trialtraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • The Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, China.
  • Sichuan Cancer Hospital, Chengdu, China.

ORCID-Profile: Bing Lin

Förderung

  • Sichuan Provincial Science and Technology Department Project

Zitieren

APA

Li, H., Ke, J., Wang, X., Xu, B., Li, Q., Wu, Z., Wang, Y., & Lin, B. (2024). Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis. Oral Diseases. https://doi.org/10.1111/odi.14745

Vancouver

Li H, Ke J, Wang X, Xu B, Li Q, Wu Z, et al. Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis. Oral Diseases. 2024. doi:10.1111/odi.14745

BibTeX
@article{Li2024,
  author = {Li, Huakang and Ke, Jianlong and Wang, Xiaoyan and Xu, Bo and Li, Qiang and Wu, Ziliang and Wang, Yue and Lin, Bing},
  title = {Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14745}
}
Kostenlos starten →